Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT05576181 · UNKNOWN

Trial details

NCT number: NCT05576181
Sponsor: Fundamenta Therapeutics, Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited

Start date: 2022-10-15
Primary completion: 2025-01-22
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.